Author

Michele Menicagli

Fondazione Pisa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:imaging· 1

Frequent Co-Authors

Carlo GambaccianiiD· 2 shared Chiara Maria MazzantiiD· 2 shared Francesca LessiiD· 2 shared Francesco PasqualettiiD· 2 shared Francesco PieriiD· 2 shared Gianmarco FerriiD· 2 shared Mariangela MorelliiD· 2 shared Orazio Santo SantonocitoiD· 2 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Carlo GambaccianiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

From Single-Cell Emergent Behaviors to Clinical Outcome: PTEN-driven Migratory Efficiency as a Potential New Vulnerability in Glioblastoma

Mariangela Morelli, Gianmarco Ferri, Francesca Lessi, Francesca Di Lorenzo, Sara Franceschi, Francesca Marchetto, Gabriele Tancreda, Tiziano Vadi, Francesco Sarnari, Tim Hohmann, Francesco Pieri, Carlo Gambacciani, Francesco Pasqualetti, Yawer Hussain Shah, Jace Singh, , Chiara Maria Mazzanti

This study identifies PTEN gain-of-function mutations as linked to increased migratory efficiency in glioblastoma cells, correlating with poorer patient survival.

bioRxiv · Mar 20, 2026 · PreprintCancer Biology

Metabolic-imaging of human glioblastoma explants: a new precision-medicine model to predict tumor treatment response early

Mariangela Morelli, Francesca Lessi, Serena Barachini, Romano Liotti, Nicola Montemurro, Paolo Perrini, Orazio Santo Santonocito, Carlo Gambacciani, Matija Snuderl, Francesco Pieri, Filippo Aquila, Azzurra Farnesi, Antonio Giuseppe Naccarato, Paolo Viacava, Francesco Cardarelli, , Chiara Maria Mazzanti

This paper develops a functional precision medicine approach using metabolic imaging to predict glioblastoma treatment response early in ex-vivo organoids, identifying responder and non-responder groups and a new molecular signature.

Frontiers in Oncology · Sep 5, 2022Peer-reviewedMolecular Biology